XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38− cells in a phase 1/2 study of patients with relapsed/refractory AML
Titel:
XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38− cells in a phase 1/2 study of patients with relapsed/refractory AML
Auteur:
Carter, Bing Z. Mak, Duncan H. Morris, Stephen J. Borthakur, Gautam Estey, Elihu Byrd, Anna L. Konopleva, Marina Kantarjian, Hagop Andreeff, Michael